NCHR Testimony at FDA on Allergy Products

January 21, 2016. Allergies can be a life-and-death situation. Treatment options for food allergies could save lives, significantly improve quality of life for many families, and reduce the number of severe reactions from occurring. We must require that clinical trials study all of the necessary variables to help families make informed treatment choices.

Read More »

Comments of the Patient, Consumer, and Public Health Coalition on Drug Interactions with Hormonal Contraceptives

December 15, 2015. As members of the Patient, Consumer, and Public Health Coalition, we support FDA’s effort to better characterize drug interactions with hormonal contraceptives since reliable and accurate information is necessary to ensure women’s health. In particular, we recommend clinical evaluation of drug interactions for all drugs that are likely to be used in women of reproductive age and that have the potential to cause birth defects, in addition to improving the quality and usefulness of information in FDA-approved labeling.

Read More »